Clearside Biomedical’s Suprachoroidal Injection Platform Featured in Multiple Oral Presentations at 42nd Annual Meeting of The ...
- Presentations highlighted data analyses across multiple disease states - - New, nonclinical data indicates potential for suprachoroidal administration of gene-based therapies - ALPHARETTA, Ga., Feb. 19, 2019 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc …